Vanguard Group’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$255M Sell
9,193,474
-57,310
-0.6% -$1.46M ﹤0.01% 1410
2025
Q3
$225M Sell
9,250,784
-455,440
-5% -$9.06M ﹤0.01% 1491
2025
Q2
$165M Buy
9,706,224
+834,932
+9% +$14.5M ﹤0.01% 1601
2025
Q1
$173M Buy
8,871,292
+1,249,303
+16% +$32.7M ﹤0.01% 1544
2024
Q4
$189M Sell
7,621,989
-222,617
-3% -$5.68M ﹤0.01% 1568
2024
Q3
$192M Sell
7,844,606
-55,773
-0.7% -$1.44M ﹤0.01% 1561
2024
Q2
$185M Buy
7,900,379
+321,611
+4% +$7.9M ﹤0.01% 1529
2024
Q1
$250M Buy
7,578,768
+413,892
+6% +$12.9M 0.01% 1375
2023
Q4
$195M Buy
7,164,876
+349,906
+5% +$8.69M ﹤0.01% 1517
2023
Q3
$164M Sell
6,814,970
-195,009
-3% -$5.23M ﹤0.01% 1539
2023
Q2
$224M Buy
7,009,979
+624,488
+10% +$20.3M 0.01% 1420
2023
Q1
$196M Buy
6,385,491
+111,861
+2% +$4.41M 0.01% 1466
2022
Q4
$245M Buy
6,273,630
+99,159
+2% +$4.44M 0.01% 1325
2022
Q3
$294M Buy
6,174,471
+927,970
+18% +$52.9M 0.01% 1147
2022
Q2
$203M Buy
5,246,501
+534,491
+11% +$21.2M 0.01% 1416
2022
Q1
$270M Buy
4,712,010
+14,745
+0.3% +$967K 0.01% 1352
2021
Q4
$374M Buy
4,697,265
+180,565
+4% +$15.5M 0.01% 1182
2021
Q3
$393M Buy
4,516,700
+1,081,128
+31% +$109M 0.01% 1132
2021
Q2
$442M Buy
3,435,572
+202,162
+6% +$16.1M 0.01% 1070
2021
Q1
$259M Buy
3,233,410
+417,780
+15% +$39.7M 0.01% 1433
2020
Q4
$230M Buy
2,815,630
+567,257
+25% +$27.9M 0.01% 1391
2020
Q3
$55.4M Buy
2,248,373
+1,082,753
+93% +$26.9M ﹤0.01% 1967
2020
Q2
$32.6M Buy
1,165,620
+1,071,678
+1,141% +$23.1M ﹤0.01% 2205
2020
Q1
$1.69M Buy
+93,942
New +$2.04M ﹤0.01% 3349

Other funds holding BEAM